News

Filter

Current filters:

TargretinInvidaHematology

1 to 9 of 96302 results

Sanofi and Regeneron's dupilumab meets all primary and secondary endpoints Phase IIa study

Sanofi and Regeneron's dupilumab meets all primary and secondary endpoints Phase IIa study

01-10-2014

French drug major Sanofi and US biotech company Regeneron's dupilumab has met all primary and secondary…

dupilumabFrancePharmaceuticalRegeneronResearchRespiratory and PulmonarySanofiUSA

ESMO 2014: Boehringer Ingelheim’s new data for afatinib and Array’s binimetinib

ESMO 2014: Boehringer Ingelheim’s new data for afatinib and Array’s binimetinib

01-10-2014

German family-owned drug major Boehringer Ingelheim has presented new data at the annual congress of…

afatinibArray BioPharmabinimetinibBoehringer IngelheimGermanyOncologyPharmaceuticalResearch

ESMO 2014: Eisai’s Halaven could provide better quality of life for breast cancer patients

ESMO 2014: Eisai’s Halaven could provide better quality of life for breast cancer patients

01-10-2014

Data posters presented at this year’s European Society for Medical Oncology (ESMO) Congress in Madrid,…

EisaiHalavenJapanOncologyPharmaceuticalResearchSpain

Salix and Progenics receive FDA approval for Relistor injection for opioid-induced constipation

Salix and Progenics receive FDA approval for Relistor injection for opioid-induced constipation

01-10-2014

Gastrointestinal specialist Salix Pharmaceuticals and Progenix Pharmaceuticals have had their Relistor…

Gastro-intestinalsPharmaceuticalProgenics PharmaceuticalsRegulationRelistorSalix PharmaceuticalsUSA

ESMO 2014: AstraZeneca’s AZD9291 and Iressa

ESMO 2014: AstraZeneca’s AZD9291 and Iressa

01-10-2014

The annual congress of the European Society for Medical Oncology (ESMO) came to a close in Madrid, Spain,…

AstraZenecaAZD9291IressaOncologyPharmaceuticalResearchUK

Diplomat pharmacy receives expanded FDA approval for Xtandi in metastatic prostate cancer

Diplomat pharmacy receives expanded FDA approval for Xtandi in metastatic prostate cancer

01-10-2014

Independent specialty pharmacy Diplomat has received expanded approval for Xtandi (enzalutamide) from…

Astellas PharmaDiplomatMedivationOncologyPharmaceuticalRegulationUSAXtandi

Eurofins Genomics expands business into Italy

Eurofins Genomics expands business into Italy

01-10-2014

Eurofins Genomics, the genomics division of Eurofins Scientific Group, has expanded its business into…

BiotechnologyEurofins GenomicsGeneticsItalyMarkets & Marketing

Ritter appoints Michael Step as chief executive

Ritter appoints Michael Step as chief executive

01-10-2014

Privately-held gastrointestinal company Ritter Pharmaceuticals has appointed Michael Step as chief executive.

BoardroomGastro-intestinalsPharmaceuticalRitterUSA

1 to 9 of 96302 results

Back to top